# Who's Afraid of Chinese Models?

> In a July 20 Stratechery essay, Ben Thompson takes on the growing anxiety over Chinese open-weight models and argues that US frontier labs are worrying about the wrong thing. His view is that Chinese models are becoming good enough and can freely distill from Western ones, which threatens the differentiation labs have counted on, but that panic and restriction are not the answer. If models commoditize, Thompson reasons, value stops accruing to whoever has the best weights and shifts instead toward those who own the compute and the customer touchpoints. In that world, trying to wall off Chinese models does little for US labs and may even accelerate the commoditization they fear. His policy prescription flips the usual instinct: rather than restrict Chinese models, actively enable strong open US alternatives, so the open ecosystem is not ceded by default. It is a characteristically contrarian read on a debate that has mostly run in the opposite direction.

_Section: [Interesting AI Articles](https://www.wortins.com/articles) · Source: Stratechery · Published Wednesday, July 22, 2026_

## Wortins' read

In a July 20 Stratechery essay, Ben Thompson takes on the growing anxiety over Chinese open-weight models and argues that US frontier labs are worrying about the wrong thing. His view is that Chinese models are becoming good enough and can freely distill from Western ones, which threatens the differentiation labs have counted on, but that panic and restriction are not the answer. If models commoditize, Thompson reasons, value stops accruing to whoever has the best weights and shifts instead toward those who own the compute and the customer touchpoints. In that world, trying to wall off Chinese models does little for US labs and may even accelerate the commoditization they fear. His policy prescription flips the usual instinct: rather than restrict Chinese models, actively enable strong open US alternatives, so the open ecosystem is not ceded by default. It is a characteristically contrarian read on a debate that has mostly run in the opposite direction.

## Source

[Read the full story at Stratechery](https://stratechery.com/)

## Related coverage

- [Prime Intellect Raises $130M Series A at $1B Valuation for Enterprise AI Agents](https://www.wortins.com/story/prime-intellect-raises-130m-series-a-at-1b-valuation-for-ent-08f9ee0e) — [TechCrunch](https://techcrunch.com/2026/07/08/prime-intellect-raises-130m-series-a-to-help-enterprises-build-their-own-ai-agents/)
- [DeepSeek V4 Landing July 24 with New Peak/Off-Peak API Pricing Model](https://www.wortins.com/story/deepseek-v4-landing-july-24-with-new-peak-off-peak-api-prici-5774b0fc) — [TechNode](https://technode.com/2026/06/30/deepseek-to-launch-v4-in-mid-july-with-new-peak-time-api-pricing/)
- [Who's Afraid of Chinese Models?](https://www.wortins.com/story/who-s-afraid-of-chinese-models-49a2c633) — [Stratechery](https://stratechery.com/2026/whos-afraid-of-chinese-models/)
- [Claude Sonnet 5: Competitive Analysis and Real-World Performance](https://www.wortins.com/story/claude-sonnet-5-competitive-analysis-and-real-world-performa-15bae87a) — [Caylent](https://caylent.com/blog/claude-sonnet-5-launch-analysis-what-changed-what-matters-and-what-to-validate)
- [TerraFirma Raises $115M Series A for AI Construction Robotics](https://www.wortins.com/story/terrafirma-raises-115m-series-a-for-ai-construction-robotics-c4e5c014) — [SiliconANGLE](https://siliconangle.com/2026/07/14/construction-automation-startup-terrafirma-raises-115m/)
- [Zoom Acquires Common Room, Sales AI Platform, to Expand Workplace Suite](https://www.wortins.com/story/zoom-acquires-common-room-sales-ai-platform-to-expand-workpl-efe47fbc) — [Spokesman Review](https://www.spokesman.com/stories/2026/jul/07/zoom-to-buy-seattle-ai-startup/)

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._